Functional characterization of human proton-coupled folate transporter/heme carrier protein 1 heterologously expressed in mammalian cells as a folate transporter

Journal of Pharmacology and Experimental Therapeutics

Volumn 322, Issue 2, 2007, Pages 469-476

  Nakai, Yasuhiro ^a   Inoue, Katsuhisa ^a   Abe, Naoki ^a   Hatakeyama, Mai ^a   Ohta, Kin Ya ^a   Otagiri, Masaki ^b   Hayashi, Yayoi ^c   Yuasa, Hiroaki ^a  

^a NAGOYA CITY UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c KINJO GAKUIN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' DIISOTHIOCYANATOSTILBENE 2,2' DISULFONIC ACID; 5 METHYLTETRAHYDROFOLIC ACID; ACETYLSALICYLIC ACID; AUROTHIOMALATE; AZATHIOPRINE; BROMSULFOPHTHALEIN; CARRIER PROTEIN; DEXAMETHASONE; DICLOFENAC; FLUFENAMIC ACID; FLURBIPROFEN; FOLIC ACID; FOLIC ACID DERIVATIVE; GREEN FLUORESCENT PROTEIN; HEME CARRIER PROTEIN 1; HEMIN; IBUPROFEN; INDOMETACIN; KETOPROFEN; LOXOPROFEN; MEFENAMIC ACID; METHOTREXATE; NAPROXEN; PHENYLBUTAZONE; PREDNISOLONE; PREDNISONE; PROTON COUPLED FOLATE TRANSPORTER; SALAZOSULFAPYRIDINE; SALICYLAMIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACIDITY; ANIMAL CELL; ARTICLE; CELL MEMBRANE POTENTIAL; CONTROLLED STUDY; DRUG EFFECT; EMBRYO; HUMAN; HUMAN CELL; INTESTINE ABSORPTION; MAMMAL CELL; NONHUMAN; PH MEASUREMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; BIOLOGICAL TRANSPORT, ACTIVE; CELL LINE; CELL MEMBRANE; DICLOFENAC; DOSE-RESPONSE RELATIONSHIP, DRUG; FOLIC ACID; GREEN FLUORESCENT PROTEINS; HUMANS; HYDROGEN-ION CONCENTRATION; INDOMETHACIN; KINETICS; MEMBRANE TRANSPORT PROTEINS; METHOTREXATE; MICROSCOPY, CONFOCAL; NIGERICIN; SULFASALAZINE; TRANSFECTION;

EID: 34547138910     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.107.122606     Document Type: Article

References (29)

1. Chiao JH, Roy K, Tolner B, Yang CH, and Sirotnak FM (1997) RFC-1 gene expression regulates folate absorption in mouse small intestine. J Biol Chem 272:11165-11170.
2. Cronstein BN (1996) Molecular therapeutics: methotrexate and its mechanism of action. Arthritis Rheum 39:1951-1960.
3. Doan T and Massarotti E (2005) Rheumatoid arthritis: an overview of new and emerging therapies. J Clin Pharmacol 45:751-762.
4. Haagsma CJ, van Riel PL, de Jong AJ, and van de Putte LB (1997) Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: a randomized, controlled, double-blind, 52 week clinical trial. Br J Rheumatol 36:1082-1088.
5. Haagsma CJ, Blom HJ, van Riel PL, van't Hof MA, Giesendorf BA, van Oppenraaij-Emmerzaal D, and van de Putte LB (1999) Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis. Ann Rheum Dis 58:79-84.
6. Itoh T, Ono K, Koido KI, Li YH, and Yamada H (2001) Stereoselectivity of the folate transporter in rabbit small intestine: studies with amethopterin enantiomers. Chirality 13:164-169.
7. Khamdang S, Takeda M, Noshiro R, Narikawa S, Enomoto A, Anzai N, Piyachaturawat P, and Endou H (2002) Interactions of human organic anion transporters and human organic cation transporters with nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther 303:534-539.
8. Klotz U (1985) Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid. Clin Pharmacokinet 10:285-302.
9. Kumar CK, Moyer MP, Dudeja PK, and Said HM (1997) A protein-tyrosine kinase-regulated, pH-dependent, carrier-mediated uptake system for folate in human normal colonic epithelial cell line NCM460. J Biol Chem 272:6226-6231.
10. Latunde-Dada GO, Takeuchi K, Simpson RJ, and McKie AT (2006) Haem carrier protein 1 (HCP1): Expression and functional studies in cultured cells. FEBS Lett 580:6865-6870.
11. Lim CK, Li FM, and Peters TJ (1988) High-performance liquid chromatography of porphyrins. J Chromatogr 429:123-153.
12. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
13. Nozaki Y, Kusuhara H, Endou H, and Sugiyama Y (2004) Quantitative evaluation of the drug-drug interactions between methotrexate and nonsteroidal antiinflammatory drugs in the renal uptake process based on the contribution of organic anion transporters and reduced folate carrier. J Pharmacol Exp Ther 309:226-234.
14. Perry J and Chanarin I (1972) Observations on folate absorption with particular reference to folate polyglutamate and possible inhibitors to its absorption. Gut 13:544-550.
15. Poe M (1977) Acidic dissociation constants of folic acid, dihydrofolic acid, and methotrexate. J Biol Chem 252:3724-3728.
16. Praetorius J, Andreasen D, Jensen BL, Ainsworth MA, Friis UG, and Johansen T (2000) NHE1, NHE2, and NHE3 contribute to regulation of intracellular pH in murine duodenal epithelial cells. Am J Physiol 278:G197-G206.
17. Qiu A, Jansen M, Sakaris A, Min SH, Chattopadhyay S, Tsai E, Sandoval C, Zhao R, Akabas MH, and Goldman ID (2006) Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell 127:917-928.
18. Said HM, Ghishan FK, and Redha R (1987) Folate transport by human intestinal brush-border membrane vesicles. Am J Physiol 252:G229-G236.
19. Schron CM, Washington C Jr, and Blitzer BL (1985) The transmembrane pH gradient drives uphill folate transport in rabbit jejunum: direct evidence for folate/hydroxyl exchange in brush border membrane vesicles. J Clin Invest 76:2030-2033.
20. Selhub J and Rosenberg IH (1981) Folate transport in isolated brush border membrane vesicles from rat intestine. J Biol Chem 256:4489-4493.
21. Seyoum E and Selhub J (1998) Properties of food folates determined by stability and susceptibility to intestinal pteroylpolyglutamate hydrolase action. J Nutr 128:1956-1960.
22. Shayeghi M, Latunde-Dada GO, Oakhill JS, Laftah AH, Takeuchi K, Halliday N, Khan Y, Warley A, McCann FE, Hider RC, et al. (2005) Identification of an intestinal heme transporter. Cell 122:789-801.
23. Sirotnak FM, Tolner B (1999) Carrier-mediated membrane transport of folates in mammalian cells. Annu Rev Nutr 19:91-122.
24. Steinberg SE (1984) Mechanisms of folate homeostasis. Am J Physiol 246:G319-G324.
25. Strum WB (1977) A pH-dependent, carrier-mediated transport system for the folate analog, amethopterin, in rat jejunum. J Pharmacol Exp Ther 203:640-645.
26. Verhoeven AC, Boers M, and Tugwell P (1998) Combination therapy in rheumatoid arthritis: updated systematic review. Br J Rheumatol 37:612-619.
27. Williams FM, Murray RC, Underhill TM, and Flintoff WF (1994) Isolation of a hamster cDNA clone coding for a function involved in methotrexate uptake. J Biol Chem 269:5810-5816.
28. Zhao R, Gao F, Hanscom M, and Goldman ID (2004) A prominent low-pH methotrexate transport activity in human solid tumors: contribution to the preservation of methotrexate pharmacologic activity in HeLa cells lacking the reduced folate carrier. Clin Cancer Res 10:718-727.
29. Zhao R, Gao F, Wang Y, Diaz GA, Gelb BD, and Goldman ID (2001) Impact of the reduced folate carrier on the accumulation of active thiamin metabolites in murine leukemia cells. J Biol Chem 276:1114-1118.